The global bipolar disorder treatment market size is expected to reach USD 5.56 billion by 2030 according to a new study by Polaris Market Research. The report “Bipolar Disorder Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Mood Stabilizer, Anti-Convulsant, Anti-Psychotic Drug, Anti-Depressant, Others); By Mechanism of Action; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Expanding predominance of problems and innovative progressions that work with the precise discovery of a patient's state of mind and mental state are a couple of the elements driving the development of this market. For example, the utilization of tricyclic antidepressants has declined throughout the years attributable to the higher occurrence of aftereffects in contrast with different medications utilized for treating these problems.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/global-bipolar-disorder-treatment-market/request-for-sample
The FDA has approved CAPLYTA, an atypical antipsychotic from the Intra-Cellular company. It is another treatment choice for people battling depression. CAPLYTA is a once day to day professionally prescribed drug that can treat depressive episodes in adults with bipolar I or II and can be taken without anyone else or alongside lithium or valproate.
According to the article published in the International Journal of Bipolar Disorders, 2021, Lithium-based drugs, the antidepressants, are considered the first line of treatment for the illness. It is mainly used for the treatment of acute disorder cases due to its anti-suicidal nature. It calms the subject by reducing its suicidal tendencies. It is also helpful in dealing with manic episodes along with mixed episodes. Lithium-based drugs are also considered mood stabilizers.
Bipolar Disorder Treatment Market Report highlights
Polaris Market Research has segmented the bipolar disorder treatment market report based on drug class, mechanism of action, distribution channel, and region:
Bipolar Disorder Treatment, Drug Class Outlook (Revenue - USD Billion, 2018 - 2030)
Bipolar Disorder Treatment, Mechanism of Action Outlook (Revenue - USD Billion, 2018 - 2030)
Bipolar Disorder Treatment, Distribution Channels Outlook (Revenue - USD Billion, 2018 - 2030)
Bipolar Disorder Treatment, Regional Outlook (Revenue - USD Billion, 2018 - 2030)